Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
Add more filters










Publication year range
1.
Nutrients ; 15(12)2023 Jun 13.
Article in English | MEDLINE | ID: mdl-37375635

ABSTRACT

Short-chain peptides derived from various protein sources have been shown to exhibit diverse bio-modulatory and health-promoting effects in animal experiments and human trials. We recently reported that the oral administration of the Tyr-Trp (YW) dipeptide to mice markedly enhances noradrenaline metabolism in the brain and ameliorates the working-memory deficits induced by the ß-amyloid 25-35 peptide (Aß25-35). In the current study, we performed multiple bioinformatics analyses of microarray data from Aß25-35/YW-treated brains to determine the mechanism underlying the action of YW in the brain and to infer the molecular mechanisms and networks involved in the protective effect of YW in the brain. We found that YW not only reversed inflammation-related responses but also activated various molecular networks involving a transcriptional regulatory system, which is mediated by the CREB binding protein (CBP), EGR-family proteins, ELK1, and PPAR, and the calcium-signaling pathway, oxidative stress tolerance, and an enzyme involved in de novo l-serine synthesis in brains treated with Aß25-35. This study revealed that YW has a neuroprotective effect against Aß25-35 neuropathy, suggesting that YW is a new functional-food-material peptide.


Subject(s)
Alzheimer Disease , Neuroprotective Agents , Mice , Humans , Animals , Dipeptides/pharmacology , Dipeptides/therapeutic use , Amyloid beta-Peptides/metabolism , Peptide Fragments/pharmacology , Peptide Fragments/therapeutic use , Brain/metabolism , Memory, Short-Term , Memory Disorders/drug therapy , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Gene Expression , Alzheimer Disease/drug therapy , Alzheimer Disease/genetics , Alzheimer Disease/metabolism
2.
Nutrients ; 13(11)2021 Oct 24.
Article in English | MEDLINE | ID: mdl-34836015

ABSTRACT

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women. Recently, various dietary interventions have been used extensively as a novel therapy against PCOS. In the present study, we show that soy isoflavone metabolites and resistant starch, together with gut microbiota modulations, were successful in decreasing the severity of PCOS-like reproductive features while increasing the expression of gut barrier markers and butyric acid in the gut. In the letrozole-induced PCOS model rats, the intake of both 0.05% soy isoflavones and 11% resistant starch, even with letrozole treatment, reduced the severity of menstrual irregularity and polycystic ovaries with a high concentration of soy isoflavones and equol in plasma. Antibiotic cocktail treatment suppressed soy isoflavone metabolism in the gut and showed no considerable effects on reducing the PCOS-like symptoms. The mRNA expression level of occludin significantly increased with soy isoflavone and resistant starch combined treatment. Bacterial genera such as Blautia, Dorea and Clostridium were positively correlated with menstrual irregularity under resistant starch intake. Moreover, the concentration of butyric acid was elevated by resistant starch intake. In conclusion, we propose that both dietary interventions and gut microbiota modulations could be effectively used in reducing the severity of PCOS reproductive features.


Subject(s)
Gastrointestinal Microbiome , Isoflavones/administration & dosage , Polycystic Ovary Syndrome/microbiology , Polycystic Ovary Syndrome/therapy , Resistant Starch/administration & dosage , Animals , Anti-Bacterial Agents , Biomarkers/analysis , Butyric Acid/metabolism , Disease Models, Animal , Equol/blood , Female , Isoflavones/blood , Letrozole , Polycystic Ovary Syndrome/chemically induced , Rats , Severity of Illness Index , Soy Foods
3.
PLoS One ; 16(2): e0246327, 2021.
Article in English | MEDLINE | ID: mdl-33544749

ABSTRACT

Acetaldehyde is the major toxic metabolite of alcohol (ethanol) and enhances fibrosis of the liver through hepatic stellate cells. Additionally, alcohol administration causes the accumulation of reactive oxygen species (ROS), which induce hepatocyte injury-mediated lipid peroxidation. Iso-α-acids, called isohumulones, are bitter acids in beer. The purpose of this study was to investigate the protective effects of iso-α-acids against alcoholic liver injury in hepatocytes in mice. C57BL/6N mice were fed diets containing isomerized hop extract, which mainly consists of iso-α-acids. After 7 days of feeding, acetaldehyde was administered by a single intraperitoneal injection. The acetaldehyde-induced increases in serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were suppressed by iso-α-acids intake. Hepatic gene expression analyses showed the upregulation of detoxifying enzyme genes, glutathione-S-transferase (GST) and aldehyde dehydrogenase (ALDH). In vitro, iso-α-acids upregulated the enzymatic activities of GST and ALDH and induced the nuclear translocation of nuclear factor-erythroid-2-related factor 2 (Nfe2l2; Nrf2), a master regulator of antioxidant and detoxifying systems. These results suggest that iso-α-acid intake prevents acetaldehyde-induced liver injury by reducing oxidative stress via Nrf2-mediated gene expression.


Subject(s)
Carboxylic Acids/pharmacology , Chemical and Drug Induced Liver Injury, Chronic/genetics , Chemical and Drug Induced Liver Injury, Chronic/prevention & control , Diet , Gene Expression Regulation , NF-E2-Related Factor 2/genetics , Acetaldehyde/metabolism , Aldehyde Dehydrogenase/metabolism , Animals , Antioxidants/metabolism , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Ethanol/metabolism , Gene Expression Regulation/drug effects , Glutathione Transferase/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Inactivation, Metabolic/drug effects , Male , Mice, Inbred C57BL , NF-E2-Related Factor 2/metabolism , Protective Agents/pharmacology , Protein Transport/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Up-Regulation/drug effects , Up-Regulation/genetics
5.
PLoS One ; 15(5): e0232233, 2020.
Article in English | MEDLINE | ID: mdl-32365077

ABSTRACT

The physiological actions of orally ingested peptides on the brain remain poorly understood. This study examined the effects of 39 orally administered synthetic Tyr-containing dipeptides on the enhancement of brain norepinephrine metabolism in mice by comparing the concentration of 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG). Although Tyr-Tyr administration increased blood and cerebral cortex (Cx) Tyr concentrations the most, Tyr-Trp increased Cx MHPG concentration the most. The oral administration of Tyr-Trp ameliorated a short-term memory deficit of a mouse model of cognitive dysfunction induced by amyloid beta peptide 25-35. Gene expression profiling of mouse brain using a microarray indicated that Tyr-Trp administration led to a wide variety of changes in mRNA levels, including the upregulation of genes encoding molecules involved in catecholamine metabolism. A comparative metabolome analysis of the Cx of mice given Tyr-Trp or Tyr-Tyr demonstrated that Tyr-Trp administration yielded higher concentrations of Trp and kynurenine pathway metabolites than Tyr-Tyr administration, as well as higher L-dopa levels, which is the initial product of catecholamine metabolism. Catecholamines were not significantly increased in the Cx of the Tyr-Tyr group compared with the Tyr-Trp group, despite a marked increase in Tyr. Presumably, Tyr-Trp administration enhances catecholamine synthesis and metabolism via the upregulation of genes involved in Tyr and Trp metabolism as well as metabolites of Tyr and Trp. These findings strongly suggest that orally ingested Tyr-Trp modulates the brain metabolome involved in catecholamine metabolism and contributes to higher brain function.


Subject(s)
Alzheimer Disease/drug therapy , Dipeptides/administration & dosage , Memory, Short-Term/drug effects , Methoxyhydroxyphenylglycol/analysis , Administration, Oral , Alzheimer Disease/chemically induced , Alzheimer Disease/genetics , Alzheimer Disease/psychology , Amyloid beta-Peptides/adverse effects , Animals , Catecholamines/biosynthesis , Cerebral Cortex/chemistry , Cerebral Cortex/drug effects , Dipeptides/pharmacology , Disease Models, Animal , Gene Expression Profiling , Gene Expression Regulation/drug effects , Gene Regulatory Networks/drug effects , Humans , Male , Metabolome/drug effects , Mice , Peptide Fragments/adverse effects
6.
Nutrients ; 12(2)2020 Feb 11.
Article in English | MEDLINE | ID: mdl-32053963

ABSTRACT

Amazake is a traditional Japanese beverage. Its main ingredients are sake cake and rice malt. In this study, we examined the effect of sake cake and rice malt on the intestinal barrier function and gut microbiota. BALB/c mice were fed a control diet or a diet containing a mixture of sake cake and rice malt powder (SRP) for four weeks. Fecal IgA values did not change between groups, but the fecal mucin level was significantly greater in the SRP-fed group. Gene expression analysis in the ileum by real-time PCR demonstrated Muc2 expression did not change, while the Muc3 expression was upregulated in the SRP-fed group. Furthermore, microbiota analysis demonstrated a change by SRP intake at the family level, and the proportion of Lactobacillaceae significantly increased in the SRP-fed group. At the genus level, the proportion of Lactobacillus also significantly increased in the SRP-fed group. These results suggest that the intake of a mixture of sake cake and rice malt improves intestinal barrier function by increasing mucin levels and inducing changes in intestinal microbiota.


Subject(s)
Animal Nutritional Physiological Phenomena , Beverages , Diet , Gastrointestinal Microbiome , Intestinal Mucosa/metabolism , Mucins/metabolism , Oryza , Animals , Feces/chemistry , Gene Expression , Ileum/metabolism , Lactobacillaceae , Male , Mice, Inbred BALB C , Mucin-3/genetics , Mucin-3/metabolism , Up-Regulation
7.
Nutr Res ; 73: 97-101, 2020 01.
Article in English | MEDLINE | ID: mdl-31945627

ABSTRACT

A recent study showed that 54% of type 2 diabetes (T2D) patients have nonalcoholic fatty liver disease, which is a risk factor for aggravation diabetic symptoms. Previous studies suggested components in maple syrup alleviated liver injury and found polyphenols as food components to improve the symptoms and complications of diabetes. Therefore, we hypothesized that a polyphenol fraction in maple syrup improves the symptoms and complications of diabetes. To address the hypothesis, we investigated the effects of a polyphenol-rich maple syrup extract (MSE) on a T2D model mice. KK-Ay mice were fed a normal or 0.1% MSE-supplemented diet for 43 days. The results showed that the levels of serum alanine aminotransferase and aspartate aminotransferase were significantly reduced in mice that ingested MSE. Hepatic genes related to lipogenesis and lipolysis were down- and upregulated, respectively, in mice that ingested MSE. These results suggest that MSE intake alleviates liver injury and suppresses lipid accumulation in the livers of T2D mice.


Subject(s)
Acer , Diabetes Mellitus, Experimental/complications , Liver Diseases/drug therapy , Plant Extracts/pharmacology , Animals , Diabetes Mellitus, Experimental/physiopathology , Disease Models, Animal , Liver/drug effects , Liver/physiopathology , Liver Diseases/etiology , Liver Diseases/physiopathology , Male , Mice
8.
Nutr Metab (Lond) ; 16: 84, 2019.
Article in English | MEDLINE | ID: mdl-31827572

ABSTRACT

BACKGROUND: Some polyphenols are known to improve the symptoms of diabetes. In the present study, we investigated the effects of a polyphenol-rich extract of maple syrup (MSx) on a diabetic mouse model. METHODS: KK-A y mice were fed a normal or 0.05% MSx-supplemented diet for 42 days. Body weight, food intake, serum biochemical parameters, and fecal total bile acid were measured. Gene expression of liver and epididymal white adipose tissue (WAT) and cecal microbiota were analyzed. Data were analyzed with an unpaired two-tailed Student's t test or Welch's t test according to the results of the F test. RESULTS: Serum low-density lipoprotein cholesterol levels were significantly reduced in mice that consumed MSx. Hepatic genes related to fatty acid degradation and cholesterol catabolism were upregulated in mice that consumed MSx. In contrast, the expression of genes related to lipid metabolism in WAT was unaffected by the intake of MSx. There were no significant differences between the two groups in terms of total bile acid level in the feces and the relative abundance of bacteria in the cecum. CONCLUSION: Our results primarily indicate that MSx can help alleviate one of the symptoms of dyslipidemia.

9.
Mol Nutr Food Res ; 63(3): e1800543, 2019 02.
Article in English | MEDLINE | ID: mdl-30411492

ABSTRACT

SCOPE: A previous study demonstrated that intake of olive pomace extract containing maslinic acid (MA), a triterpene, effectively prevents and alleviates arthritis in animals and humans. Here, the molecular mechanisms involved in the anti-arthritis effect of MA have been elucidated by determining gene expression changes induced by olive-derived MA intake in collagen antibody-induced arthritis (CAIA) mice. METHODS AND RESULTS: Mice are divided into the untreated (CT), CAIA (CA), and CAIA administered MA (CA + MA) groups. The CA + MA mice are fed MA at a daily dose of 200 mg kg-1 of body weight from day 1. CAIA is then induced on day 8 and evaluated on day 12. Arthritis symptoms are alleviated, and the gene expression of inflammatory cytokines is reduced in the CA + MA group compared with the CA group. A DNA microarray analysis of synovial membranes reveals that MA alters the expression levels of genes related to inflammation, including glucocorticoid responses, immune responses, and the extracellular matrix. CONCLUSIONS: The preventive effect of MA on arthritis is attributable to the promotion of tissue formation as well as suppression of inflammation in the synovium via inactivation of Toll-like receptor signaling and downregulation of leukotrienes through the glucocorticoid receptor.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Arthritis, Experimental/drug therapy , Triterpenes/pharmacology , Animals , Male , Mice , Mice, Inbred DBA , Synovial Membrane/drug effects , Synovial Membrane/metabolism
10.
JCI Insight ; 3(24)2018 12 20.
Article in English | MEDLINE | ID: mdl-30568036

ABSTRACT

White adipose tissue (WAT) can dynamically expand and remodel through adipocyte hypertrophy and hyperplasia. The relative contribution of these 2 mechanisms to WAT expansion is a critical determinant of WAT function and dysfunction in obesity. However, little is known about the signaling systems that determine the mechanisms of WAT expansion. Here, we show that the GPCR LPA4 selectively activates Gα12/13 proteins in adipocytes and limits continuous remodeling and healthy expansion of WAT. LPA4-KO mice showed enhanced expression of mitochondrial and adipogenesis genes and reduced levels of inhibitory phosphorylation of PPARγ in WAT, along with increased production of adiponectin. Furthermore, LPA4-KO mice showed metabolically healthy obese phenotypes in a diet-induced obesity model, with continuous WAT expansion, as well as protection from WAT inflammation, hepatosteatosis, and insulin resistance. These findings unravel a potentially new signaling system that underlies WAT plasticity and expandability, providing a promising therapeutic approach for obesity-related metabolic disorders.


Subject(s)
Adipose Tissue/metabolism , GTP-Binding Protein alpha Subunits, G12-G13/metabolism , Obesity/metabolism , Receptors, Purinergic/metabolism , Tissue Expansion/methods , Adipocytes/metabolism , Adipogenesis/genetics , Adiponectin/metabolism , Adipose Tissue/pathology , Adipose Tissue, White/metabolism , Animals , Diet, High-Fat , Disease Models, Animal , Fibroblasts , Gene Expression Regulation , Glucose Tolerance Test , Insulin/metabolism , Insulin Resistance , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/metabolism , Obesity/genetics , Obesity/pathology , PPAR gamma/metabolism , Phosphorylation , Receptors, Purinergic/genetics , Signal Transduction
11.
Food Sci Nutr ; 6(6): 1657-1663, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30258609

ABSTRACT

SCOPE: Previously, we showed that the intake of a persimmon peel (PP) extract altered hepatic gene expression associated with the insulin signaling pathway and enhanced tyrosine phosphorylation of insulin receptors in nonobese type 2 diabetic Goto-Kakizaki rats. Our objective was to evaluate the effect of fat-soluble PP extract on obese type 2 diabetic KK-Ay mice with insulin resistance. METHODS AND RESULTS: KK-Ay mice were fed a diet mixed with 0.1% of the extract for 8 weeks. The total ketone body levels in the plasma of PP extract-fed mice were significantly lower than those in the normal diet-fed mice. Hepatic nonesterified palmitic acid content was higher in the PP extract-fed mice than in normal diet-fed mice. The hepatic gene expression profiles of the treated mice indicated upregulation of fatty acid synthesis and downregulation of inflammation-associated genes, predicting SREBP-1c and PPARγ activation. CONCLUSION: These results suggest that the PP extract enhances hepatic fatty acid synthesis via SREBP-1c and PPARγ, as well as anti-inflammatory activity in KK-Ay mice.

12.
Mol Nutr Food Res ; 62(12): e1700828, 2018 06.
Article in English | MEDLINE | ID: mdl-29663642

ABSTRACT

SCOPE: Wakame is an edible seaweed that is a common constituent in the Japanese diet. Previous studies showed that wakame consumption is associated with the prevention of metabolic syndrome, but the molecular mechanisms underlying the protective effects are poorly understood. METHODS AND RESULTS: To determine if the expression of hepatic genes is affected by ingestion of the brown seaweed Undaria pinnatifida (wakame), rats were fed a diet containing 0, 0.1, or 1.0 g per 100 g dried wakame powder for 28 days. Administration of 1% wakame significantly decreased serum total cholesterol levels. Hepatic gene expression was investigated using DNA microarray analysis, and the results showed that wakame suppresses the lipogenic pathway by downregulating SREBF-1. Moreover, bile acid biosynthesis and gluconeogenesis were promoted by upregulation of the PPAR signaling pathway, which leads to a reduction in the accumulation of cholesterol and promotion of ß-oxidation. CONCLUSIONS: These results suggest that wakame ingestion affects glucose and lipid metabolism by altering the expression of SREBF-1 and PPAR signal-related genes.


Subject(s)
Anti-Obesity Agents/pharmacology , Glucose/metabolism , Lipid Metabolism/drug effects , Seaweed , Undaria , Administration, Oral , Animals , Cholesterol/blood , Dietary Supplements , Gene Expression Regulation/drug effects , Gene Ontology , Liver/drug effects , Liver/physiology , Male , Oligonucleotide Array Sequence Analysis , Peroxisome Proliferator-Activated Receptors/genetics , Peroxisome Proliferator-Activated Receptors/metabolism , Rats, Sprague-Dawley , Sterol Regulatory Element Binding Protein 1/genetics
13.
Br J Nutr ; 117(1): 1-11, 2017 01.
Article in English | MEDLINE | ID: mdl-28091360

ABSTRACT

Ingestion of collagen peptide (CP) elicits beneficial effects on the body, including improvement in blood lipid profiles, but the underlying mechanisms remain unclear. The purpose of this study was to investigate the effects of CP ingestion on the liver, which controls lipid metabolism in the body. Male BALB/cCrSlc mice were bred with the AIN-93M diet containing 14 % casein or the AIN-93M-based low-protein diet containing 10 % casein or a diet containing 6 % casein+4 % CP for 10 weeks (n 12/group). Total, free and esterified cholesterol levels in the blood decreased in the CP group. DNA microarray analysis of the liver revealed that expressions of genes related to lipid metabolic processes such as the PPAR signalling pathway and fatty acid metabolism increased in the CP group compared with the 10 % casein group. The expressions of several genes involved in steroid metabolic process, including Cyp7a1 and Cyp8b1, were decreased, despite being targets of transcriptional regulation by PPAR. These data suggest that lipid metabolism in the liver is altered by CP ingestion, and the decrease in blood cholesterol levels in the CP group is not due to enhancement of the steroid metabolic process. On the other hand, expressions of genes related to the unfolded protein response (UPR) significantly decreased at the mRNA level, suggesting that CP ingestion lowers endoplasmic reticulum stress. Indeed, protein levels of phosphorylated inositol-requiring enzyme 1 decreased after CP ingestion. Taken together, CP affects the broader pathways in the liver - not only lipid metabolism but also UPR.


Subject(s)
Collagen/pharmacology , Gene Expression Regulation/drug effects , Lipid Metabolism/physiology , Liver/metabolism , Unfolded Protein Response/drug effects , Administration, Oral , Animals , Collagen/administration & dosage , Lipid Metabolism/genetics , Male , Mice
14.
Mol Nutr Food Res ; 61(2)2017 02.
Article in English | MEDLINE | ID: mdl-27605424

ABSTRACT

SCOPE: Maple syrup contains various polyphenols and we investigated the effects of a polyphenol-rich maple syrup extract (MSXH) on the physiology of mice fed a high-fat diet (HFD). METHODS AND RESULTS: The mice fed a low-fat diet (LFD), an HFD, or an HFD supplemented with 0.02% (002MSXH) or 0.05% MSXH (005MSXH) for 4 weeks. Global gene expression analysis of the liver was performed, and the differentially expressed genes were classified into three expression patterns; pattern A (LFD < HFD > 002MSXH = 005MSXH, LFD > HFD < 002MSXH = 005MSXH), pattern B (LFD < HFD = 002MSXH > 005MSXH, LFD > HFD = 002MSXH < 005MSXH), and pattern C (LFD < HFD > 002MSXH < 005MSXH, LFD > HFD < 002MSXH > 005MSXH). Pattern A was enriched in glycolysis, fatty acid metabolism, and folate metabolism. Pattern B was enriched in tricarboxylic acid cycle while pattern C was enriched in gluconeogenesis, cholesterol metabolism, amino acid metabolism, and endoplasmic reticulum stress-related event. CONCLUSION: Our study suggested that the effects of MSXH ingestion showed (i) dose-dependent pattern involved in energy metabolisms and (ii) reversely pattern involved in stress responses.


Subject(s)
Acer/chemistry , Diet, High-Fat , Gene Expression Regulation , Liver/physiology , Animals , Dietary Sugars/pharmacology , Dietary Supplements , Fatty Acids/metabolism , Liver/drug effects , Male , Mice, Inbred C57BL
15.
PLoS One ; 11(5): e0155386, 2016.
Article in English | MEDLINE | ID: mdl-27187182

ABSTRACT

A high phosphorus (HP) diet causes disorders of renal function, bone metabolism, and vascular function. We previously demonstrated that DNA microarray analysis is an appropriate method to comprehensively evaluate the effects of a HP diet on kidney dysfunction such as calcification, fibrillization, and inflammation. We reported that type IIb sodium-dependent phosphate transporter is significantly up-regulated in this context. In the present study, we performed DNA microarray analysis to investigate the effects of a HP diet on the liver, which plays a pivotal role in energy metabolism. DNA microarray analysis was performed with total RNA isolated from the livers of rats fed a control diet (containing 0.3% phosphorus) or a HP diet (containing 1.2% phosphorus). Gene Ontology analysis of differentially expressed genes (DEGs) revealed that the HP diet induced down-regulation of genes involved in hepatic amino acid catabolism and lipogenesis, while genes related to fatty acid ß-oxidation process were up-regulated. Although genes related to fatty acid biosynthesis were down-regulated in HP diet-fed rats, genes important for the elongation and desaturation reactions of omega-3 and -6 fatty acids were up-regulated. Concentrations of hepatic arachidonic acid and eicosapentaenoic acid were increased in HP diet-fed rats. These essential fatty acids activate peroxisome proliferator-activated receptor alpha (PPARα), a transcription factor for fatty acid ß-oxidation. Evaluation of the upstream regulators of DEGs using Ingenuity Pathway Analysis indicated that PPARα was activated in the livers of HP diet-fed rats. Furthermore, the serum concentration of fibroblast growth factor 21, a hormone secreted from the liver that promotes fatty acid utilization in adipose tissue as a PPARα target gene, was higher (p = 0.054) in HP diet-fed rats than in control diet-fed rats. These data suggest that a HP diet enhances energy expenditure through the utilization of free fatty acids released via lipolysis of white adipose tissue.


Subject(s)
Diet , Lipid Metabolism , Liver/metabolism , Phosphorus/metabolism , Adipose Tissue/metabolism , Amino Acids/metabolism , Animals , Biomarkers , Body Weight , Computational Biology/methods , Gene Expression Profiling , Gene Expression Regulation , Gene Ontology , Lipid Metabolism/genetics , Lipids/blood , Metabolic Networks and Pathways , Rats , Regulatory Sequences, Nucleic Acid , Transcriptome
16.
Biosci Biotechnol Biochem ; 80(6): 1149-54, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26967115

ABSTRACT

Activating transcription factor 4 (ATF4) is a transcription factor with an important biological activity. ATF4 is induced by various stresses, such as endoplasmic reticulum stress, through the phosphorylation of eukaryotic translation initiation factor 2α. ATF4 is also involved in lipid metabolism. In the present study, we performed a microarray experiment to identify new ATF4 target genes, particularly those involved in lipid metabolism, and identified C12orf39, CSTA, and CALCB as novel ATF4 target genes. An amino acid response element (AARE) as an ATF4-binding site is present in the promoter regions of these genes. In a detailed analysis using luciferase assay, we showed that ATF4 activated C12orf39 promoter activity and that this activation was diminished by deletion or mutation of the AARE sequence in the promoter region. Our results suggest that C12orf39, CSTA, and CALCB are novel ATF4 target genes and that C12orf39 promoter activity is activated by ATF4 through AARE.


Subject(s)
Activating Transcription Factor 4/genetics , Calcitonin Gene-Related Peptide/genetics , Cystatin A/genetics , Gene Expression Regulation, Neoplastic , Hepatocytes/metabolism , Peptide Hormones/genetics , Activating Transcription Factor 4/metabolism , Binding Sites , Calcitonin Gene-Related Peptide/metabolism , Cell Line, Tumor , Cystatin A/metabolism , Eukaryotic Initiation Factor-2/genetics , Eukaryotic Initiation Factor-2/metabolism , Gene Expression Profiling , Genes, Reporter , Hepatocytes/pathology , Humans , Lipid Metabolism/genetics , Luciferases/genetics , Luciferases/metabolism , Microarray Analysis , Mutation , Peptide Hormones/metabolism , Protein Binding , Response Elements , Signal Transduction
17.
World J Gastroenterol ; 21(35): 10091-103, 2015 Sep 21.
Article in English | MEDLINE | ID: mdl-26401074

ABSTRACT

AIM: To investigate the effects of broccoli sprout extract (BSEx) on liver gene expression and acute liver injury in the rat. METHODS: First, the effects of BSEx on liver gene expression were examined. Male rats were divided into two groups. The Control group was fed the AIN-76 diet, and the BSEx group was fed the AIN-76 diet containing BSEx. After a 10-d feeding period, rats were sacrificed and their livers were used for DNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) analyses. Next, the effects of BSEx on acute liver injury were examined. In experiments using acute liver injury models, 1000 mg/kg acetaminophen (APAP) or 350 mg/kg D-galactosamine (D-GalN) was used to induce injury. These male rats were divided into four groups: Control, BSEx, Inducer (APAP or D-GalN), and Inducer+BSEx. The feeding regimens were identical for the two analyses. Twenty-four hours following APAP administration via p.o. or D-GalN administration via i.p., rats were sacrificed to determine serum aspartate transaminase (AST) and alanine transaminase (ALT) levels, hepatic glutathione (GSH) and thiobarbituric acid-reactive substances accumulation and glutathione-S-transferase (GST) activity. RESULTS: Microarray and real-time RT-PCR analyses revealed that BSEx upregulated the expression of genes related to detoxification and glutathione synthesis in normal rat liver. The levels of AST (70.91 ± 15.74 IU/mL vs 5614.41 ± 1997.83 IU/mL, P < 0.05) and ALT (11.78 ± 2.08 IU/mL vs 1297.71 ± 447.33 IU/mL, P < 0.05) were significantly suppressed in the APAP + BSEx group compared with the APAP group. The level of GSH (2.61 ± 0.75 nmol/g tissue vs 1.66 ± 0.59 nmol/g tissue, P < 0.05) and liver GST activity (93.19 ± 16.55 U/g tissue vs 51.90 ± 16.85 U/g tissue, P < 0.05) were significantly increased in the APAP + BSEx group compared with the APAP group. AST (4820.05 ± 3094.93 IU/mL vs 12465.63 ± 3223.97 IU/mL, P < 0.05) and ALT (1808.95 ± 1014.04 IU/mL vs 3936.46 ± 777.52 IU/mL, P < 0.05) levels were significantly suppressed in the D-GalN + BSEx group compared with the D-GalN group, but the levels of AST and ALT in the D-GalN + BSEx group were higher than those in the APAP + BSEx group. The level of GST activity was significantly increased in the D-GalN + BSEx group compared with the D-GalN group (98.04 ± 15.75 U/g tissue vs 53.15 ± 8.14 U/g tissue, P < 0.05). CONCLUSION: We demonstrated that BSEx protected the liver from various types of xenobiotic substances through induction of detoxification enzymes and glutathione synthesis.


Subject(s)
Brassica/chemistry , Chemical and Drug Induced Liver Injury/prevention & control , Gene Expression Regulation/drug effects , Liver/drug effects , Plant Extracts/pharmacology , Protective Agents/pharmacology , Acetaminophen , Animals , Biomarkers/blood , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/pathology , Cytoprotection , Disease Models, Animal , Galactosamine , Gene Expression Profiling/methods , Glutathione/metabolism , Inactivation, Metabolic/drug effects , Inactivation, Metabolic/genetics , Liver/metabolism , Liver/pathology , Male , Oligonucleotide Array Sequence Analysis , Phytotherapy , Plant Extracts/isolation & purification , Plants, Medicinal , Protective Agents/isolation & purification , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Seedlings , Time Factors
18.
Physiol Genomics ; 47(8): 355-63, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26058835

ABSTRACT

Dietary collagen hydrolysate has been hypothesized to improve skin barrier function. To investigate the effect of long-term collagen hydrolysate administration on the skin, we evaluated stratum corneum water content and skin elasticity in intrinsically aged mice. Female hairless mice were fed a control diet or a collagen hydrolysate-containing diet for 12 wk. Stratum corneum water content and skin elasticity were gradually decreased in chronologically aged control mice. Intake of collagen hydrolysate significantly suppressed such changes. Moreover, we used DNA microarrays to analyze gene expression in the skin of mice that had been administered collagen hydrolysate. Twelve weeks after the start of collagen intake, no significant differences appeared in the gene expression profile compared with the control group. However, 1 wk after administration, 135 genes were upregulated and 448 genes were downregulated in the collagen group. This suggests that gene changes preceded changes of barrier function and elasticity. We focused on several genes correlated with functional changes in the skin. Gene Ontology terms related to epidermal cell development were significantly enriched in upregulated genes. These skin function-related genes had properties that facilitate epidermal production and differentiation while suppressing dermal degradation. In conclusion, our results suggest that altered gene expression at the early stages after collagen administration affects skin barrier function and mechanical properties. Long-term oral intake of collagen hydrolysate improves skin dysfunction by regulating genes related to production and maintenance of skin tissue.


Subject(s)
Collagen/administration & dosage , Collagen/pharmacology , Gene Expression Profiling , Oligonucleotide Array Sequence Analysis , Skin/drug effects , Skin/metabolism , Administration, Oral , Animals , Cluster Analysis , Dermis/drug effects , Dermis/metabolism , Down-Regulation/drug effects , Down-Regulation/genetics , Elasticity , Epidermis/drug effects , Epidermis/metabolism , Female , Fishes , Gene Ontology , Hydrolysis , Mice, Hairless , RNA, Messenger/genetics , RNA, Messenger/metabolism , Up-Regulation/drug effects , Up-Regulation/genetics
19.
Biosci Biotechnol Biochem ; 79(11): 1893-7, 2015.
Article in English | MEDLINE | ID: mdl-25982262

ABSTRACT

Effects of the administration of maple syrup extract (MSX) on hepatic gene expression were investigated in mice fed a high-fat diet. Gene annotation enrichment analysis based on gene ontology revealed some changes in the expression of genes related to lipid metabolism and the immune response in MSX-fed mice. Detailed analysis of these data indicated that MSX ingestion mitigates hepatic inflammation.


Subject(s)
Inflammation/drug therapy , Liver/drug effects , Plant Extracts/administration & dosage , Transcriptome/genetics , Acer/chemistry , Animals , Diet, High-Fat/adverse effects , Gene Expression/drug effects , Inflammation/pathology , Lipid Metabolism/drug effects , Lipid Metabolism/genetics , Liver/pathology , Mice , Plant Extracts/chemistry , Transcriptome/drug effects
20.
Biosci Biotechnol Biochem ; 78(11): 1935-8, 2014.
Article in English | MEDLINE | ID: mdl-25117913

ABSTRACT

We performed comprehensive transcriptome analysis of Peyer's patches to elucidate the effects of oral administration of Lactobacillus plantarum strain AYA in mice. Using microarray analysis, we identified 124 upregulated and 144 downregulated genes for four weeks after the start of dietary supplementation with AYA. Gene Ontology analysis revealed that the genes for immune function were enriched in the upregulated gene set.


Subject(s)
Gene Expression Regulation , Lactobacillus plantarum/immunology , Peyer's Patches/immunology , Probiotics , Administration, Oral , Animals , Dietary Supplements , Mice , Microarray Analysis , Peyer's Patches/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL